Michael Loiacono

Chief Financial Officer, Marker Therapeutics, Inc.

Companies

Marker Therapeutics, Inc.Chief Accounting Officer Mar 12, 2020 to Mar 1, 2023¹
Marker Therapeutics, Inc.Chief financial officer Aug 25, 2016 to Oct 23, 2018²

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMarker Therapeutics, Inc., Chief Accounting Officer
2
SEC EDGARMarker Therapeutics, Inc., Chief financial officer